Metabolic fingerprinting reveals link between dietary fat restriction and therapy response
18 June 2020
New research from the Cancer Grand Challenges Rosetta team has identified a potential metabolic weakness in cancer that could be amenable to treatment. The findings, published in Cell earlier this month, focused on exploring whether the metabolic changes known to occur at a cellular level in breast cancer can stratify patients and help to identify novel and potentially targetable vulnerabilities.
Led by Dr George Poulogiannis at the Institute of Cancer Research in the UK, the team used cutting edge technology – the Intelligent Knife (iKnife) – to measure real time differences in tumour metabolism. In mouse models, they have unravelled the mechanisms behind tumour-driving metabolic changes that occur as a result of the common breast cancer mutation PI3KCA.
They observed enhanced arachidonic acid (AA) production that is known to promote tumour growth and reduce anti-cancer immune responses. They also found a unique way to address the negative implications of this genetic change. The novel combination of inhibition of the enzyme cPLA2, known to mediate the cellular release of arachidonic acid, and a fatty acid free diet, to remove external sources of AA, reduced tumour growth.
Although it is still early day, George says “I think this is one of the first few studies that shows a dietary fat restriction plays a major role in therapy response.”
This is a step further towards understanding the complex relationship between cellular metabolism, cancer and diet. And is just one part of the Rosetta programme, spearheaded by Professor Josephine Bunch, that is creating a ‘Google earth of cancer’.
More stories like this
CANCER GRAND CHALLENGES SCIENTISTS TURN TECH TO TACKLE COVID-19
24 April 2020
Category: People & Community
The global research community has rallied to tackle COVID-19 – and members of the Cancer Grand Challenges community are among those leading the charge. Several of our researchers have repurposed their innovative tools to help fight COVID-19.